Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jul
24
2015
Modernizing and Coordinating the Regulatory System of Biotechnology Products Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
23
2015
Biosimilars, the BPCIA, and Amgen v. Sandoz: The Federal Circuit’s First Attempt To Make Sense of “A Riddle Wrapped in a Mystery Inside an Enigma” Mintz
Jul
23
2015
The Riddle Wrapped in a Mystery Inside an Enigma – the Federal Circuit decides Amgen v. Sandoz – is anyone happy? Michael Best & Friedrich LLP
Jul
22
2015
FDA Issues Warning Letter to Corporate Sponsor of Clinical Trial Mintz
Jul
21
2015
Cheers! A Brief Look at Recent Changes to the Illinois Liquor Control Act Heyl, Royster, Voelker & Allen, P.C.
Jul
21
2015
DNA Sequencing Patents: Simultaneous Invention As Secondary Evidence Of Obviousness Foley & Lardner LLP
Jul
20
2015
The Patchwork Solidifies: GMO Bill Moves Forward in the House Mintz
Jul
17
2015
SEC Settles With Stock Promoters in Medical Marijuana Stock Manipulation Scheme Katten
Jul
17
2015
Federal GMO-Labeling Bill is on the Move as the House Agriculture Committee Approves H.R. 1599, the Safe and Accurate Food Labeling Act Michael Best & Friedrich LLP
Jul
17
2015
Prescription Drug Overdoses May Be Compensable Under Workers' Comp Holland & Hart LLP
Jul
16
2015
UK Judicial Review Of Official Veterinarian Over Beef Carcase: Food Standards Agency Victory Squire Patton Boggs (US) LLP
Jul
15
2015
National Safety Council Urges Employers to Take Steps to Address Employee Addiction to Opioid Pain Medications Jackson Lewis P.C.
Jul
14
2015
Two Biopharmaceutical Companies Resolve Allegations of Violating the False Claims Act By Underpaying Rebates, and Agree to Pay U.S. Government $54.4 Million Settlement Tycko & Zavareei LLP
Jul
14
2015
FDA Bans Imports from Emcure Pharmaceuticals – New Whistleblower Opportunity Mahany Law
Jul
14
2015
Contract Manufacturing Makes Angiomax Patents Invalid Under On Sale Bar Foley & Lardner LLP
Jul
13
2015
Calorie Count Delay: FDA Extends Compliance Date for Menu Labeling Rules Morgan, Lewis & Bockius LLP
Jul
13
2015
The Medicines Company v. Hospira - Preparation of validation batches by a contract manufacturer for FDA submission creates an on-scale bar Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
10
2015
FDA Extends Compliance Deadline for Food Establishment Labeling Rule Armstrong Teasdale
Jul
10
2015
GMOs in the Hotseat: White House to Overhaul Regulatory Framework on Biotechnology Mintz
Jul
10
2015
Final Drug Shortage Reporting Rules Will Go Into Effect September 2015 Mintz
Jul
10
2015
First Federal Appellate Court Holds a NonCash Reverse Payment Subject to Antitrust Scrutiny: Is the Third Circuit's Decision in King Drug a Turning Point? Proskauer Rose LLP
Jul
9
2015
FDA Announces New Menu Labeling Compliance Date McDermott Will & Emery
Jul
9
2015
FDA to Focus on “Complementary” Diagnostics in Addition to Companion Diagnostics Covington & Burling LLP
Jul
9
2015
Beer-Maker Puts an End to Brewhaha: Anheuser Busch Agrees to Settle Second of Two Class Action Lawsuits over Beer Origin Disclaimers Proskauer Rose LLP
Jul
8
2015
Colorado Supreme Court: Medical Use of Marijuana Not ‘Lawful’ Jackson Lewis P.C.
Jul
7
2015
The Compounding Regulations Surrounding Drug Compounding McBrayer, McGinnis, Leslie and Kirkland, PLLC
Jul
2
2015
FDA Releases Draft Guidance on its Voluntary Qualified Importer Program Faegre Drinker
Jul
2
2015
Second Circuit Appellate Court Weighs In on Pharmaceutical “Product Hopping” McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins